On the last day of AGBT, attendees crowded the room for the session everyone had been waiting for: New Genomic Frontiers, highlighting sequencing advances from Pacific Biosciences, Complete Genomics, Life Technologies, Ion Torrent, and Helicos. At Genetic Interference, Luke Jostins gives a quick run-down of each and he notes that "we are starting to see a divergence in sequencing technologies … This means that the scientists themselves can more closely tailor their choice of tech to fit their situation."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Human Knockouts

'Spin Any Story'

Peek Inside

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."